MESA REDONDA EN EL CONGRESO ISPOR
La sesión ISPOR Spain Chapter, en la mesa del Congreso ISPOR, que se celebrará virtualmente el 18 de noviembre de 15h a 16h
El objetivo de la mesa redonda de ISPOR Spain Chapter es realizar un brainstorming interno del capítulo que servirá para preparar el futuro debate que tendremos en la Jornada post-ISPOR.
Evaluación económica, precio y reembolso: el despertar del día de la marmota
INTRODUCCIÓN
The scale up of pharmaceutical innovation is facing an even more challenging environment than imagined. Within this context some initiatives have arisen across EU with the willingness to combine an always complex equation: early access to innovation for the patients that may benefit the most at a fair price, health care expenditure cost control, and incentives to pharma and biotech innovation for health solutions.
New and detailed proposals from the Pricing and Reimbursement Advisor Committee (CAPF) has been published in Spain. These proposals will be the basis for an open discussion about the implications of these measures in the future of the Pricing and Reimbursement processes and negotiations in Spain.
PROGRAMA
Presentation of the main points of the proposals of the CAPF
- MAX BROSA. General Manager, Oblikue Consulting
Discussion
- MAX BROSA. General Manager, Oblikue Consulting
- ALVARO HIDALGO. Professor and Director of the Research Group in Health Economics and Health Management, UCLM / Weber Foundation President / Director ISPOR Spain Chapter
- JAVIER SOTO. Head of Health Economics and Outcomes Research Department, Pfizer
- PALOMA GONZÁLEZ. Market Access Lead Southern Europe, Dextom / Director ISPOR Spain Chapter
Moderator
- CARME PINYOL. Head of Pricing and Market Access Southern Europe, Pierre Fabre / ISPOR Spain Chapter President
Patrocinadores:
